Current management of colorectal hepatic metastasis

Evaluation of Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer

(2009) Myrddin Rees et al.   ANNALS OF SURGERY

Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer

(2009) Jolien Tol et al.   NEW ENGLAND JOURNAL OF MEDICINE

Trends in Nontherapeutic Laparotomy Rates in Patients Undergoing Surgical Therapy for Hepatic Colorectal Metastases

(2008) Timothy M. Pawlik et al.   ANNALS OF SURGICAL ONCOLOGY

Colorectal Liver Metastases

(2008) Ana L. Gleisner   ARCHIVES OF SURGERY

Cancer Statistics, 2008

(2008) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Operative Mortality After Hepatic Resection: Are Literature-Based Rates Broadly Applicable?

(2008) Bolanle Asiyanbola et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

(2008) Bernard Nordlinger et al.   LANCET

K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer

(2008) Christos S. Karapetis et al.   NEW ENGLAND JOURNAL OF MEDICINE

Expanding Criteria for Resectability of Colorectal Liver Metastases

(2008) T. M. Pawlik et al.   ONCOLOGIST

Bevacizumab Improves the Overall and Progression-Free Survival of Patients with Metastatic Colorectal Cancer Treated with 5-Fluorouracil-Based Regimens Irrespective of Baseline Risk

(2008) Fairooz Kabbinavar et al.   ONCOLOGY

Bilobar Colorectal Liver Metastases: Treatment Options

(2008) Daniel Jaeck et al.   Surgical Oncology Clinics of North America